CD8A and cancer: Given the substantial advantages of nanomaterials in cancer therapy, such as enhanced targeting precision, superior drug stability and bioavailability, and the augmented permeability and retention effect, researchers are endeavoring to design an array of nanomedicines to reprogram TAM phenotypes and augment CD8+ T cell functionality.